Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening-Reference-Cited by-同舟云学术

Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening

Published:2013-03 Issue:5 Volume:23 Page:1177-1181
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Nettekoven Matthias,Fingerle Jürgen,Grether Uwe,Grüner Sabine,Kimbara Atsushi,Püllmann Bernd,Rogers-Evans Mark,Röver Stephan,Schuler Franz,Schulz-Gasch Tanja,Ullmer Christoph

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference42 articles.

1. Is lipid signaling through cannabinoid 2 receptors part of a protective system?

2. Modulation of the Endocannabinoid System in Cardiovascular Disease

3. Cannabinoids and the gut: New developments and emerging concepts

4. CB2 receptors as new therapeutic targets for liver diseases

5. A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Stereoselective Synthesis of Diethyl cis- and trans-(4-Hydroxy-1,2,3,4-tetrahydroquinolin-2-yl)phosphonates and Ethyl Phenylphosphinates from Quinolin-4(1H)-one;Synthesis;2023-08-31

2. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

3. (3 + 2)-Annulation of 1,3-N,Si-tetraorganosilane reagents TsHNCH₂SiBnR¹R² with arynes for efficient synthesis of 3-silaindolines;Organic Chemistry Frontiers;2022

4. Rational drug design of CB2 receptor ligands: from 2012 to 2021;RSC Advances;2022

5. Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010;Pharmaceutical Patent Analyst;2021-05